Texas Yale Capital Corp. Arcturus Therapeutics Holdings Inc. Transaction History
Texas Yale Capital Corp.
- $2.28 Billion
- Q3 2024
A detailed history of Texas Yale Capital Corp. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Texas Yale Capital Corp. holds 16,000 shares of ARCT stock, worth $287,680. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,000
Previous 16,000
-0.0%
Holding current value
$287,680
Previous $389,000
4.63%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ARCT
# of Institutions
178Shares Held
25.6MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$84.4 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$47.6 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$41.6 Million0.62% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.28MShares$40.9 Million0.04% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$37.8 Million0.46% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $478M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...